British Airways deal faces tight review: status of U.K.-U.S. treaty could be crucial

Article Abstract:

British Airways' (BA) plans to phase in its alliance with American Airlines could see major opposition from regulators. BA proposed to phase in the alliance over a four or five-year period. However, both BA and American have a strong hold on UK-US air routes. Regulators in the US are studying a wide range of proposed cooperative arrangements. One such arrangement could have American placing its code on a London-to-Munich BA flight. This would allow American to sell a through ticket from New York to Munich. Both BA and American claim they should be allowed to have such marketing partnerships in accordance with existing treaties. US officials have said that they oppose any greater BA-American partnership without a new liberalized air treaty between the US and the UK.

United States, Scheduled Airlines, Scheduled Air Transportation, Strategic alliances, Air Transportation, Scheduled, And Air Courier Services, Airlines, British Airways PLC, American Airlines Inc.

---

Britain is accused of spying on U.N.: claim by U.K. ex-minister adds to charges plaguing Blair since Baghdad fell

Article Abstract:

Clare Short, the United Kingdom's former minister for international development, alleges that her nation obtained covert transcripts of conversations by United Nations Secretary-General Kofi Annan prior to the Iraq war. This newest accusation could further reduce public opinion of Prime Minister Tony Blair, as support for the war lessens.

Legal issues & crime, Company legal issue, Investigations, Blair, Tony, Political aspects, Public opinion, United Nations, Iraq War, 2003-, Espionage, British, British espionage

---

Similar abstracts:

• Abstracts: British Airways' net falls 1.2% on write-down, U.K. security alert. Dba's new owner has experience in aviation world
• Abstracts: British Airways order for superjumbo jetliners gives Airbus needed boost. BAE snaps up U.K. contract for trainer jets
• Abstracts: Novartis offers to buy rest of Chiron. Novartis agrees to acquire the rest of Chiron for $5.1 billion. Biotech industry heads toward IPO boomlet
• Abstracts: Japan's election, set for Nov.9, could speed economic changes. Drop in Japanese bond prices fails to frighten economists
• Abstracts: Ahold's net increases 76% on higher sales, lower interest. Supermarket company to post its first-half results Nov. 7

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.